BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 16, Issue 2
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (4053)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.
Item 
Count 
PDF95
WORD13
HTML1945
Figures (1-1)292
Tables (1-3)320
 Sum=2665
Featured Article
The chart showing Browse series, Download series.
Item 
Count 
Browse214
Download505
 Sum=719
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse129
Download458
 Sum=587
Feb 27, 2024 (publication date) through Apr 12, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Zhou XQ, Li YP, Dang SS. Precision targeting in hepatocellular carcinoma: Exploring ligand-receptor mediated nanotherapy. World J Hepatol 2024; 16(2): 164-176 [PMID: 38495282 DOI: 10.4254/wjh.v16.i2.164]
URL: https://www.wjgnet.com/1948-5182/full/v16/i2/164.htm
Number Citing Articles
1
Howard D Lee, Li-Yun Yuan. Nano-revolution in hepatocellular carcinoma: A multidisciplinary odyssey - Are we there yet?. World Journal of Hepatology 2024; 16(5): 684-687 doi: 10.4254/wjh.v16.i5.684
2
Balaji Palanisamy, Abul Kalam Azad Mandal. Unlocking the potential: Receptor-mediated targeted drug delivery in cancer therapy. Pathology - Research and Practice 2025; 270: 155955 doi: 10.1016/j.prp.2025.155955
3
Ayhan Bergal, Muberra Andac, Francesco Trotta. Cyclodextrin-based chemically modified pH-Responsive new kind of aldehyde-functionalized nanosponge nanoparticles for doxorubicin hydrochloride delivery. Journal of Drug Delivery Science and Technology 2025; 107: 106853 doi: 10.1016/j.jddst.2025.106853
4
Mohammad S. Alzahrani, Bandar Almutairy, Yusuf S. Althobaiti, Hashem O. Alsaab. Recent Advances in RNA Interference-Based Therapy for Hepatocellular Carcinoma: Emphasis on siRNA. Cell Biochemistry and Biophysics 2024; 82(3): 1947 doi: 10.1007/s12013-024-01395-6
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345